Economic Navigation and Strengthening to Research Unrestricted Services for Transgender Women (ENTRUST)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18+
SponsorUniversity of Central Florida
About this trial
The overall hypothesis is that stabilizing transgender women financially while providing them tailored counselling will increase their odds of them linking to substance use services, PrEP services if they do not have HIV, and transgender women who are living with HIV will be more adherent to their ART treatment.
Eligibility criteria
Qualifiers
Aged ≥18 years
Male at birth
Identify as a woman/transgender woman
Should not be consistently using PrEP (less than four doses per week)
Disqualifiers
Unwilling to adhere to study procedures
Participation in an HIV vaccine trial
Have a life-threatening SUD*
Any condition, that in the opinion of the study staff, would make participation in the study unsafe, or interfere with achieving the study objective such as medical conditions which prevents the use of PrEP
Trial design
Treatments tested in this trial
- Baseline
- ENTRUST
- Control
Treatment groups
110 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Central Florida
Lead sponsor
Sunserve
Collaborator
Survivor's Pathway
Collaborator
26Health
Collaborator
National Institute of Drug Abuse
Collaborator
Source ClinicalTrials.gov